Project Details
Description
Phase II Study of Biweekly Carboplatin and Gemcitabine with Bevacizumab as 1st Line Treatment in Patients with Advanced, Inoperable Stage III B/IV NSCLC
| Status | Finished |
|---|---|
| Effective start/end date | 1/3/07 → 7/2/10 |
Funding
- HUBERT H HUMPHREY CANCER CTR
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.